Description
Protein Engineering Market Forecast till 2027
Protein Engineering Market overview
The protein engineering market is anticipated to register a significant CAGR of 7.62% during the review period to surpass USD 3,023.29 million by 2027. Nowadays, the protein engineering market is acquiring fame because of less utilization of non-protein drugs. The consequences of protein drugs are positive in the clinical area.
Because of this, the interest in protein engineering is expanding in numerous areas. Protein engineering has an enormous degree as it can decrease the shortcoming of clinical medications. Likewise, the proficiency and viability of the medication are high.
Generally, the pervasiveness of protein engineering brings about more cardiovascular fixes. The utilization of the protein engineering device is prompting considerably more advantages in the clinical area.
The therapy of disease, immune system, and relocate dismissals are conceivable through protein engineering. Additionally, the all-around designed methods of protein in drugs are giving remarkable outcomes and conveyance. The expanding innovative work interest in the wellbeing area is the vital justification behind the popularity.
Likewise, really advertising and commercialization of the medications is one more justification for more interest. There is a mixture of protein engineering techniques and applications in the impending years.
Particularly the biotechnical drug organization holds the most extreme protein piece of the pie. The ascent of the reception of silicon model protein in this area is promoting a positive effect on the protein engineering market. It will prompt further improvement of the general market.
Segment overview
The global protein engineering market has been classified based on product, protein type, technology, and end-user.
In terms of product segment, the global market has been divided into Instruments, Consumables, and Services, and software. Based on Protein type the market has been classified into Coagulation factors, Monoclonal antibodies, Growth hormones, Vaccines, Vaccines, and Interferon.
Based on Technology type the market has been categorized into Irrational protein design and Rational protein design.
The End-user segment segregates the global protein engineering market into Academic research institutes, biopharmaceutical companies, and Contract research organizations.
Regional analysis
The region-specific analysis of the global protein engineering market is studied across Asia Pacific, North America, and Europe.
North America is set to overwhelm the market with the biggest offer. Further, the developing venture is the main consideration for a market extension. The market advancement rate will be higher for the North American region. The rising technique of extent protein engineering is driving more interest.
The Asia Pacific market is rapidly occupying in the projected timeframe. The high advancement is a direct result of more care about protein engineering. The progression in genomics is the earnest driver for the market.
Further, the advancement of proteomics is higher around here. The regulatory drives for the medicine-based market are higher. The allotments support protein engineering turning out to be more. Additionally, Europe is standing up to direct revenue for the market around here. Europe will see greater improvement during the review period.
Prominent Players
The key player of the protein engineering market is ProteoGenix, Bio-Rad Laboratories, PhyNexus, Inc, Thermo Fisher Scientific, Broker Corporation, Zymeworks, Inc, Waters Corporation, Aspira Chemical, Danaher Corporation, InvivoGen, New England Biolabs, Enantis S.R.O, New England Biolabs, Promega Corporation, and New England Biolabs.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.
Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Protein supplements market : Global Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030
Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
4.2.2 INCREASING INVESTMENTS IN SYNTHETIC BIOLOGY
4.3 RESTRAINTS
4.3.1 LACK OF TRAINED PROFESSIONALS
4.4 OPPORTUNITIES
4.4.1 EMERGING MARKETS OF PROTEIN ENGINEERING
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE PROTEIN ENGINEERING MARKET
5.3.1 IMPACT ON DEMAND
5.3.2 IMPACT ON RESEARCH
5.3.3 IMPACT ON SUPPLY CHAIN
6 GLOBAL PROTEIN ENGINEERING MARKET, BY TYPE
6.1 OVERVIEW
6.2 INSTRUMENT
6.3 REAGENT
6.4 SERVICES & SOFTWARE
7 GLOBAL PROTEIN ENGINEERING MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 FOOD & DETERGENT INDUSTRIES
7.3 ENVIRONMENTAL
7.4 MEDICAL
7.5 BIOPOLYMER PRODUCTION
7.6 NANOBIOTECHNOLOGY
8 GLOBAL PROTEIN ENGINEERING MARKET, BY METHOD
8.1 OVERVIEW
8.2 RATIONAL PROTEIN DESIGN
8.3 DIRECTED EVOLUTION
9 GLOBAL PROTEIN ENGINEERING MARKET, BY END USER
9.1 OVERVIEW
9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES
9.3 CONTRACT ENGINEERING ORGANIZATIONS
9.4 ACADEMIC RESEARCH INSTITUTES
10 GLOBAL PROTEIN ENGINEERING MARKET, BY REGION
10.1 OVERVIEW
10.2 AMERICAS
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 CANADA
10.2.2 SOUTH AMERICA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 FRANCE
10.3.1.3 UK
10.3.1.4 ITALY
10.3.1.5 SPAIN
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 UAE
10.5.2 SAUDI ARABIA
10.5.3 OMAN
10.5.4 KUWAIT
10.5.5 QATAR
10.5.6 REST OF THE MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE PROTEIN ENGINEERING MARKET
11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE PROTEIN ENGINEERING MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES/PIPELINE DRUGS
11.6.2 PARTNERSHIP/COLLABORATION
11.6.3 EXPANSIONS/AGREEMENT
11.6.4 MARKETING STRATEGY
11.6.5 MERGERS & ACQUISITIONS
11.7 MAJOR PLAYERS SALES ANALYSIS
11.7.1 SALES & OPERATING INCOME
11.8 MAJOR PLAYERS R&D ANALYSIS
12 COMPANY PROFILES
12.1 THERMO FISHER SCIENTIFIC INC.
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS/SERVICES OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 BIO-RAD LABORATORIES, INC.
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS/SERVICES OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 GENSCRIPT
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS/SERVICES OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 AGILENT TECHNOLOGIES, INC.
12.4.1 COMPANY OVERVIEWS
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS/SERVICES OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 PERKINELMER INC.
12.5.1 COMPANY OVERVIEWS
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS/SERVICES OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 BRUKER
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS/SERVICES OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 KEY STRATEGIES
12.7 WATERS CORPORATION
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS/SERVICES OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 MERCK KGAA
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS/SERVICES OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 PROMEGA CORPORATION
12.9.1 COMPANY OVERVIEWS
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS/SERVICES OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 DANAHER CORPORATION (AB-SCIEX)
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS/SERVICES OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
